Why do some people have antibodies to ancient viral fragments?
Autoantibodies to human endogenous retrovirus‐K are frequently detected in health and disease and react with multiple epitopes
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Nearly 1 in 3 healthy people have antibodies targeting ancient viral fragments in their DNA.
People assume these immune responses only happen in disease—but here, healthy individuals show the same reaction, just at lower levels.
Practical Takeaways
If you have lupus, ask your doctor if HERV-K antibody testing is available—it may help track disease activity.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
Nearly 1 in 3 healthy people have antibodies targeting ancient viral fragments in their DNA.
People assume these immune responses only happen in disease—but here, healthy individuals show the same reaction, just at lower levels.
Practical Takeaways
If you have lupus, ask your doctor if HERV-K antibody testing is available—it may help track disease activity.
Publication
Journal
Clinical & Experimental Immunology
Year
2002
Authors
C. Hervé, E. Lugli, A. Brand, D. Griffiths, P. Venables
Related Content
Claims (6)
In autoimmune disease, the immune system produces antibodies that target the body's own molecules and tissues.
Antibodies against a specific protein from an ancient viral sequence in human DNA are found in about 29% of healthy people and in 32% to 47% of people with certain autoimmune rheumatic diseases.
People with systemic lupus erythematosus (SLE) have higher levels of antibodies targeting a specific viral-like protein fragment compared to healthy individuals and people with other autoimmune diseases.
Certain antibodies in the human immune system bind to specific parts of proteins derived from ancient viral sequences in the human genome. One of these binding sites, GKTCPKEIPKGSKNT, has a unique chemical composition and does not resemble known self-proteins or infectious viruses.
Studies show that people with type 1 diabetes do not have higher levels of antibodies against HERV-K envelope proteins compared to people without the disease.